EYE TECH CARE is a young medical device company with one goal to develop non-invasive therapeutic medical devices utilizing proprietary high-intensity focused ultrasound (HIFU) technology.
The first device to go to market will be the EyeOP1® designed to treat refractory glaucoma in a simple, predictable, safe and effective manner using the Ultrasound Circular Cyclo Coagulation (or ‘UC3’) technique.
EYE TECH CARE has developed EyeOP1®, a unique, non-invasive medical device to treat glaucoma with ultrasound. EYE TECH CARE’s team have designed the only therapeutic procedure that currently addresses all patients with uncontrolled glaucoma, irrespective of their prior treatment history.
The mechanism of action of the device is based on Ultrasound Ciliary Plasty (UCP). This non-invasive, extremely precise treatment, offers a very good tolerance profile without significant side effects. It can be performed in less than three minutes in an outpatient care setting.
Due to the favorable safety profile, this procedure can be used for a broad spectrum of patients, from early stages to more advanced cases. UCP treatment offers an innovative alternative to existing therapeutic options utilized to control intraocular pressure.
